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Introduction: Diagnosing extra-pulmonary tuberculosis continues to be a challenge for both
infectious disease specialists and microbiologists.
Objectives: This prospective study was done to evaluate the performance of two DNA-based
methods for the detection of extra-pulmonary tuberculosis in comparison with the con-
ventional culture technique.
Methods: All extra-pulmonary specimens received by the Kuwait National Tuberculosis Ref-
erence from October 2011 until August 2013 were included in the study. Smears were
stained by Ziehl Neelson (Merck, Germany) followed by inoculation of the specimens into
GeneXpert MTB/RIF assay (Cepheid, USA), ProbTec ET PCR (Becton Dickinson) and MGIT
960 (Becton Dickinson). Urine was inoculated into Lowenstein Jensen media (MAST).
Results: A total of 1674 extra-pulmonary specimens (pleural fluid 553, ascetic fluid 194,
cerebrospinal fluid [CSF] 85, Urine 67, other sterile body fluids 153, fine needle aspirates
[FNA] 301, pus 181, tissue 102, swabs 27 and stool 11) were evaluated. Out of 155 extra-pul-
monary specimens that grew Mycobacterium tuberculosis (MTB) by culture, 143 were positive
by GeneXpert comparedwith 128 by ProbTec with a sensitivity of 92% and 83%, respectively.
Out of 1517 specimens that did not grow by culture, 52 were detected by GeneXpert while 46
were detected by ProbTec with specificity of 96.5% and 96.9%, respectively. All the 4 smear-
negative CSF samples which grew MTB were positive by GeneXpert with a sensitivity of
100% compared with only 2 detected by ProbTec with a sensitivity of 50%. Additionally,
all CSF specimens that did not grow by culture were negative by both the molecular meth-
ods showing 100% specificity. Of the 3 smear-positive urine specimens that grew by culture,
all were positive, and of the 64 samples that did not grow by culture, all were negative by
both the molecular methods with a sensitivity and specificity of 100%. For other sterile body
fluids the sensitivity and specificity of both the methods were 68% and 99%, respectively.
Finally, for FNA, pus and tissue, the sensitivity of GeneXpert was 97% compared with
86% for ProbTec.
Conclusion: DNA-based technology looks promising for the rapid diagnosis of extra-pul-
monary tuberculosis with an overall better performance of GeneXpert over ProbTec.
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